Net Income Common - Erasca Inc (NASDAQ:ERAS) - Alpha Spread

Erasca Inc
NASDAQ:ERAS

Watchlist Manager
Erasca Inc Logo
Erasca Inc
NASDAQ:ERAS
Watchlist
Price: 2.97 USD 2.77% Market Closed
Market Cap: 810.3m USD
Have any thoughts about
Erasca Inc?
Write Note

Erasca Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Erasca Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Erasca Inc
NASDAQ:ERAS
Net Income (Common)
-$125m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.3B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$1.1B
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Erasca Inc's Net Income (Common)?
Net Income (Common)
-125m USD

Based on the financial report for Dec 31, 2023, Erasca Inc's Net Income (Common) amounts to -125m USD.

What is Erasca Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-7%

Over the last year, the Net Income (Common) growth was 49%. The average annual Net Income (Common) growth rates for Erasca Inc have been -7% over the past three years .

Back to Top